EP. 1: Dr Daniel J. George Discusses the Use of Biomarkers in RCC Treatment
July 7th 2023While there are reliable biomarkers to monitor disease progression and guide treatment decisions for tyrosine kinase inhibitors in renal cell carcinoma (RCC), there is a need for biomarkers for immunotherapies.
Read More
EP. 3: Dr Rana McKay on First-Line Therapies for Metastatic Renal Cell Carcinoma
May 30th 2023In this first part of a 2-part series, Rana R. McKay, MD, associate professor of Medicine and Urology, Moores Cancer Center, University of California San Diego, provides an overview of the treatment landscape for advanced renal cell carcinoma.
Read More
EP. 4: Dr Rana McKay on Second-Line Treatment Options for Advanced RCC
May 23rd 2023In the second part of a 2-part series, Rana R. McKay, MD, associate professor of Medicine and Urology, Moores Cancer Center, University of California San Diego, discusses second-line treatment options for advanced renal cell carcinoma (RCC).
Read More
EP. 5: Dr Alan Tan on the Options for Patients With Advanced RCC
May 9th 2023Survival is good for patients when renal cell carcinoma (RCC) is caught early, but options for advanced disease present challenges, explained Alan Tan, MD, an assistant professor in the Division of Hematology, Oncology and Cell Therapy at Rush Medical College and the director of GU Medical Oncology.
Read More
EP. 6: Dr Alan Tan Provides Overview of RCC Prevalence, Presentation, Diagnosis
May 2nd 2023Many times, renal cell carcinoma (RCC) is found incidentally, as a result of something else, said Alan Tan, MD, an assistant professor in the Division of Hematology, Oncology and Cell Therapy at Rush Medical College and the director of GU Medical Oncology.
Read More